BMO Capital analyst Etzer Darout raised the price target on Nuvalent (NASDAQ: NUVL) to $134.00 (from $132.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE